Follow this preprint
Real-World Effectiveness of Nirsevimab Against Respiratory Syncytial Virus: A Test-Negative Case-Control Study
Hanmeng Xu, Camilla Aparicio, Aanchal Wats, Barbara L. Araujo, Virginia E. Pitzer, Joshua L. Warren, Eugene D. Shapiro, Linda M. Niccolai, Daniel M. Weinberger, View ORCID ProfileCarlos R. Oliveira
doi: https://doi.org/10.1101/2024.09.12.24313545
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Hanmeng Xu
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Camilla Aparicio
2Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, CT, USA
MDAanchal Wats
2Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, CT, USA
MD, MPHBarbara L. Araujo
2Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, CT, USA
Virginia E. Pitzer
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
ScDJoshua L. Warren
3Department of Biostatistics, Yale School of Public Health, New Haven, CT, USA
Eugene D. Shapiro
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
2Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, CT, USA
MDLinda M. Niccolai
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
PhDDaniel M. Weinberger
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
PhDCarlos R. Oliveira
1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
2Department of Pediatrics, Section of Infectious Diseases and Global Health, Yale School of Medicine, New Haven, CT, USA
4Department of Biostatistics, Section of Health Informatics, Yale School of Public Health, New Haven, CT, USA
MD, PhD
Posted September 12, 2024.
Real-World Effectiveness of Nirsevimab Against Respiratory Syncytial Virus: A Test-Negative Case-Control Study
Hanmeng Xu, Camilla Aparicio, Aanchal Wats, Barbara L. Araujo, Virginia E. Pitzer, Joshua L. Warren, Eugene D. Shapiro, Linda M. Niccolai, Daniel M. Weinberger, Carlos R. Oliveira
medRxiv 2024.09.12.24313545; doi: https://doi.org/10.1101/2024.09.12.24313545
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (414)
- Allergy and Immunology (735)
- Anesthesia (216)
- Cardiovascular Medicine (3150)
- Dermatology (268)
- Emergency Medicine (468)
- Epidemiology (13115)
- Forensic Medicine (15)
- Gastroenterology (875)
- Genetic and Genomic Medicine (4938)
- Geriatric Medicine (455)
- Health Economics (758)
- Health Informatics (3109)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (981)
- Medical Education (460)
- Medical Ethics (121)
- Nephrology (508)
- Neurology (4693)
- Nursing (249)
- Nutrition (695)
- Oncology (2421)
- Ophthalmology (689)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (523)
- Pediatrics (1258)
- Primary Care Research (530)
- Public and Global Health (7258)
- Radiology and Imaging (1623)
- Respiratory Medicine (950)
- Rheumatology (463)
- Sports Medicine (408)
- Surgery (524)
- Toxicology (65)
- Transplantation (223)
- Urology (193)